# clm_9F8BAD62BE47

subject: Merck & Co. (/record/merck.md)  
predicate: quarterly_research_and_development  
value: 913,000,000 United States dollar  
valid_from: 2009-09-30  
valid_to: 2010-03-31  
published: 2009-10-29  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_49575E9AC377  
last_updated: 2026-11-08  
cite: AsOf. "Merck & Co. quarterly research and development: 913,000,000 United States dollar", as of 2009-09-30 (until 2010-03-31). Claim clm_9F8BAD62BE47, https://asof.is/claim/clm_9F8BAD62BE47, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2009, filed 2009-10-29  

## Sources

- https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm (primary, SEC EDGAR 10-Q Q3 FY2009, published 2009-10-29)

## Supersedes

- [Merck & Co.](/record/merck.md) | quarterly_research_and_development | 863,000,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_9F8BAD62BE47](/claim/clm_9F8BAD62BE47.md) | [clm_C47CB8AEE9D1](/claim/clm_C47CB8AEE9D1.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.